A little BP muscle never hurts especially if you’re trying to change the narrative.
A big paradigm shift away from the powerful amyloid lobbyists requires some of our own. Who knows, depending on who we get on our side, we might even get the Alzheimer’s Association to back us.
I believe they sent an army of scientists and patients to fight for Leqembi. Can’t find the article. Maybe some else has it on hand.
Sadly, it’s who you know much of the time. Maybe all of the time. Big money comes with big power and influence.
Missling needs all the help he can get especially with no validate surrogate biomarkers and what is on the surface seemingly nonstandard measurements.
Sometimes you gotta play the game. So far we haven’t. Definitely not with Wall Street. It may even get us some momentum in the press and with analysts. We need to be in the conversation instead of being dismissed. Otherwise we can easily fade
Another 3-5 years is not worth it. It reminds me of the Shark Tank. What’s a good product if no one knows. If no one knows, no one cares.
News 
Market Data 
Discover 
